Ausgabe 4/2018
Inhalt (10 Artikel)
Economic Impact of Oral Therapies for Chronic Lymphocytic Leukemia—the Burden of Novelty
Talal Hilal, Jeffrey A. Betcher, Jose F. Leis
Disordered Immune Regulation and its Therapeutic Targeting in Myelodysplastic Syndromes
Kathryn S. Ivy, P. Brent Ferrell Jr
Shutting Down Acute Myeloid Leukemia and Myelodysplastic Syndrome with BCL-2 Family Protein Inhibition
Prashant Sharma, Daniel A Pollyea
Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia
Mehrdad Hefazi, Mark R. Litzow
Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues
Christopher Wenzinger, Eli Williams, Alejandro A. Gru
Novel Therapies in Acute Lymphoblastic Leukemia
Kathleen W. Phelan, Anjali S. Advani
Adult T Cell Leukemia-Lymphoma (ATL): State of the Art
Adrienne A. Phillips, Janine C. K. Harewood
Pathogenesis of Enteropathy-Associated T Cell Lymphoma
Udit Chander, Rebecca J. Leeman-Neill, Govind Bhagat
Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review
Waseem Lone, Aisha Alkhiniji, Jayadev Manikkam Umakanthan, Javeed Iqbal
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going Forward
Jessica T. Leonard, Brandon Hayes-Lattin